Gene therapy in nonhuman primate models of human autoimmune disease. (Q35122173)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Gene therapy in nonhuman primate models of human autoimmune disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

t'Hart BA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Vervoordeldonk M

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Tak PP

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

890-901

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12732874%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Interferon beta in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Major histocompatibility complex class II polymorphisms in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Asymptomatic synovitis precedes clinically manifest arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Collagen autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Collagen-induced arthritis in an outbred group of rhesus monkeys comprising responder and nonresponder animals. Relationship between the course of arthritis and collagen-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Collagen arthritis--what can it teach us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Collagen-induced arthritis, an animal model of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Resistance to collagen-induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Cytokines in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Gene therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Toxicity of a first-generation adenoviral vector in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Suppression of collagen‐induced arthritis through adenovirus‐mediated transfer of a modified tumor necrosis factor α receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Gene therapy for autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Non-human primate models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

The common marmoset: a new world primate species with limited Mhc class II variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Role of costimulation in the induction of the IL-12/IL-12 receptor pathway and the development of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

The use of nonhuman primate models to improve gene transfer into haematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Gene transfer into hematopoietic stem cells of nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Lentiviral vectors: turning a deadly foe into a therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Studies illuminate cause of fatal reaction in gene-therapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Drug delivery to damaged brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

Sex-linked differences in susceptibility of cynomolgus monkeys to type II collagen-induced arthritis. Evidence that epitope-specific immune suppression is involved in the regulation of type II collagen autoantibody formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

The anti-arthritic and immunosuppressive effects of cyclosporin A on collagen-induced arthritis in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Designing novel therapeutic strategies for rheumatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

A new primate model for multiple sclerosis in the common marmoset

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Autoimmunity in non-human primates: the role of major histocompatibility complex and T cells, and implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021

Gene transfer through the blood–nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302017

7 January 2021